Browse the complete record of transactions filed by Lang Peter Frederick, Chief Financial Officer. Officer active across 1 companies, notably Aerie Pharmaceuticals INC. Aggregated, 1 disclosures have been recorded. The latest transaction was disclosed on 18 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Peter Frederick Lang is the Chief Financial Officer at Aerie Pharmaceuticals Inc, a biopharmaceutical company. He is responsible for the company's financial management, including budgeting and financial analysis. With a strong background in the healthcare sector, Peter plays a key role in strategic financial decision-making. His expertise in finance and regulation is essential to support Aerie Pharmaceuticals' growth.